NASDAQ: QNRX
Quoin Pharmaceuticals Ltd Stock Forecast, Predictions & Price Target

Analyst price target for QNRX

Based on 3 analysts offering 12 month price targets for Quoin Pharmaceuticals Ltd

Min Forecast
$14.00+272.34%
Avg Forecast
$17.33+360.98%
Max Forecast
$20.00+431.91%

Should I buy or sell QNRX stock?

Based on 3 analysts offering ratings for Quoin Pharmaceuticals Ltd.

Strong Buy
Strong Buy
3 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their QNRX stock forecasts and price targets.

QNRX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-10-19
lockedlocked$00.00+00.00%2026-10-12
lockedlocked$00.00+00.00%2026-09-23

1 of 1

Forecast return on equity

Is QNRX forecast to generate an efficient return?

Company
N/A
Industry
18.67%
Market
160.87%

Forecast return on assets

Is QNRX forecast to generate an efficient return on assets?

Company
N/A
Industry
19.68%

QNRX earnings per share forecast

What is QNRX's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
-$6.52
Avg 2 year Forecast
-$2.62
Avg 3 year Forecast
-$2.32

QNRX revenue forecast

What is QNRX's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$19.8M

QNRX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
QNRX$3.76$17.33+360.98%Strong Buy
TVRD$1.34$9.20+586.57%Strong Buy
KTTA$0.53$3.00+463.91%Buy
LPCN$1.59$4.00+151.57%Hold
ATYR$6.77$50.00+638.55%Buy

Quoin Pharmaceuticals Stock Forecast FAQ

Is Quoin Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: QNRX) stock is to Strong Buy QNRX stock.

Out of 3 analysts, 3 (100%) are recommending QNRX as a Strong Buy, 0 (0%) are recommending QNRX as a Buy, 0 (0%) are recommending QNRX as a Hold, 0 (0%) are recommending QNRX as a Sell, and 0 (0%) are recommending QNRX as a Strong Sell.

If you're new to stock investing, here's how to buy Quoin Pharmaceuticals stock.

What is QNRX's earnings growth forecast for 2026-2028?

(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 11.66%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 32.69%.

Quoin Pharmaceuticals's earnings in 2026 is -$19,587,909.On average, 8 Wall Street analysts forecast QNRX's earnings for 2026 to be -$1,095,653,903, with the lowest QNRX earnings forecast at -$1,300,135,834, and the highest QNRX earnings forecast at -$768,005,279. On average, 7 Wall Street analysts forecast QNRX's earnings for 2027 to be -$441,113,311, with the lowest QNRX earnings forecast at -$733,283,201, and the highest QNRX earnings forecast at -$307,202,112.

In 2028, QNRX is forecast to generate -$389,896,145 in earnings, with the lowest earnings forecast at -$581,683,079 and the highest earnings forecast at -$225,987,760.

What is QNRX's revenue growth forecast for 2026-2028?

(NASDAQ: QNRX) Quoin Pharmaceuticals's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 31.94%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.33%.

Quoin Pharmaceuticals's revenue in 2026 is $0.On average, 9 Wall Street analysts forecast QNRX's revenue for 2026 to be $0, with the lowest QNRX revenue forecast at $0, and the highest QNRX revenue forecast at $0. On average, 8 Wall Street analysts forecast QNRX's revenue for 2027 to be $0, with the lowest QNRX revenue forecast at $0, and the highest QNRX revenue forecast at $0.

In 2028, QNRX is forecast to generate $3,334,832,776 in revenue, with the lowest revenue forecast at $395,478,581 and the highest revenue forecast at $7,434,055,699.

What is QNRX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: QNRX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 19.68%.

What is QNRX's Price Target?

According to 3 Wall Street analysts that have issued a 1 year QNRX price target, the average QNRX price target is $17.33, with the highest QNRX stock price forecast at $20.00 and the lowest QNRX stock price forecast at $14.00.

On average, Wall Street analysts predict that Quoin Pharmaceuticals's share price could reach $17.33 by Oct 19, 2027. The average Quoin Pharmaceuticals stock price prediction forecasts a potential upside of 360.98% from the current QNRX share price of $3.76.

What is QNRX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: QNRX) Quoin Pharmaceuticals's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that QNRX's EPS will be -$6.52 for 2026, with the lowest EPS forecast at -$7.73, and the highest EPS forecast at -$4.57. On average, analysts forecast that QNRX's EPS will be -$2.62 for 2027, with the lowest EPS forecast at -$4.36, and the highest EPS forecast at -$1.83. In 2028, QNRX's EPS is forecast to hit -$2.32 (min: -$3.46, max: -$1.34).

What is QNRX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: QNRX) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.